Literature DB >> 15539677

The pros and cons of essential medicines for rich countries.

Marcus M Reidenberg1, Tom Walley.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15539677      PMCID： PMC527703          DOI： 10.1136/bmj.329.7475.1172

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The free trade agreement between Australia and the United States.

Authors:  Peter Drahos; David Henry
Journal:  BMJ       Date:  2004-05-29

Review 2.  The concept of essential medicines: lessons for rich countries.

Authors:  Hans V Hogerzeil
Journal:  BMJ       Date:  2004-11-13

3.  Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group.

Authors:  L A Bero; R Grilli; J M Grimshaw; E Harvey; A D Oxman; M A Thomson
Journal:  BMJ       Date:  1998-08-15

Review 4.  Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

Authors:  J M Kremer
Journal:  Ann Intern Med       Date:  2001-04-17       Impact factor: 25.391
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.